Translate page

Perspectives on CML management

from Professor Jerry Radich
Fred Hutchinson Cancer Research Center
Seattle, USA

  • Assessment of existing therapies in CML including new data on bosunitib in front-line therapy
  • Emerging new therapies for CML and how they could come into practice
  • Perspectives on treatment discontinuation
  • Challenges of CML management in the emerging economic regions: access to treatment and testing

{rscomments off}